Matches in Nanopublications for { ?s ?p "[These unexpected findings identify a novel mechanism of tumor lymphangiogenesis and metastasis induced by cancer cell expression of podoplanin, suggesting that reagents designed to interfere with podoplanin function might be developed as therapeutics for patients with advanced cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP920688.RAsOUq6-Ueg8mS3b5UIkXHC5HUOUHtZkFVWga2rwjoSbU130_assertion description "[These unexpected findings identify a novel mechanism of tumor lymphangiogenesis and metastasis induced by cancer cell expression of podoplanin, suggesting that reagents designed to interfere with podoplanin function might be developed as therapeutics for patients with advanced cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP920688.RAsOUq6-Ueg8mS3b5UIkXHC5HUOUHtZkFVWga2rwjoSbU130_provenance.
- NP824658.RAPZdHkraBS8xDfQsjr8AiHGUe8nIdsw9avhJH-68FsEg130_assertion description "[These unexpected findings identify a novel mechanism of tumor lymphangiogenesis and metastasis induced by cancer cell expression of podoplanin, suggesting that reagents designed to interfere with podoplanin function might be developed as therapeutics for patients with advanced cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP824658.RAPZdHkraBS8xDfQsjr8AiHGUe8nIdsw9avhJH-68FsEg130_provenance.
- NP849250.RAsToEwn7QKxsOOGusItB6iOOkT-HUtlbnI7ksRLsIs38130_assertion description "[These unexpected findings identify a novel mechanism of tumor lymphangiogenesis and metastasis induced by cancer cell expression of podoplanin, suggesting that reagents designed to interfere with podoplanin function might be developed as therapeutics for patients with advanced cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP849250.RAsToEwn7QKxsOOGusItB6iOOkT-HUtlbnI7ksRLsIs38130_provenance.